NCT04807335

Study of CT001 in Healthy Volunteers

Bioavailability Study of Intranasal CT001 in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 14 (actual)
• Sponsor: Cessatech A/S · Industry
• Sex: Male
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

A phase 1, three arms, cross over comparison study to evaluate bioavailability, pharmacokinetics and safety of intra nasal CT001 in healthy volunteers.

Detailed description

A single site phase 1 study including a randomised, open label, three periods, single dose, cross over design in 12 healthy male volunteers.

Conditions

• Bioavailability

Interventions

Type	Name	Description
DRUG	CT001	nasal spray
DRUG	Ketamine	iv single dose
DRUG	sufentanil	iv single dose

Timeline

• Start date: 2021-03-17
• Primary completion: 2021-06-02
• Completion: 2021-06-02
• First posted: 2021-03-19
• Last updated: 2021-08-24

Locations

1 site across 1 country: Denmark